Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure

Journal of Clinical and Experimental Hepatology

Volumn 5, Issue S1, 2015, Pages S96-S103

  Butterworth, Roger F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acute liver failure; Hepatic encephalopathy; Intracranial hypertension; Microglial activation; Neuroinflammation

Indexed keywords

ACETYLCYSTEINE; AMMONIA; ASPARTIC ACID; ETANERCEPT; FLUMAZENIL; GLUTAMINE; LACTIC ACID; MEMANTINE; MINOCYCLINE; ORNITHINE; ORNITHINE ASPARTATE; PHENYLACETIC ACID;

ACUTE LIVER FAILURE; ASTROCYTE; BRAIN EDEMA; BRAIN METABOLISM; CELL VOLUME; DRUG MECHANISM; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOTHERMIA; LIVER PROTECTION; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 84924571755     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.02.004     Document Type: Review

References (67)

1. Aggarwal S., Kramer D., Yonas H., et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology 1994, 19:80-87.
2. Kato M., Hughes R.D., Keays R.T., Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992, 15:1060-1066.
3. Thumburu K.K., Dhiman R.K., Vasishta R.K., et al. Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure. JNeurochem 2014, 128:617-627.
4. Potvin M., Morrison H.F., Hinchey E.J., et al. Cerebral abnormalities in hepatectomised rats with acute hepatic coma. Lab Invest 1984, 50:560-564.
5. Chastre A., Belanger M., Nguyen B.N., Butterworth R.F. Lipo-polysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. Liver Int 2014, 34:353-361.
6. Vaquero J., Chung C., Cahill M.E., Blei A.T. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis 2003, 23:259-269.
7. Clemmesen J.O., Larsen F.S., Kondrup J., et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentrations. Hepatology 1999, 29:648-653.
8. Bernal W., Hall C., Karvellas C.J., et al. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007, 46:1844-1852.
9. Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002, 17:221-227.
10. Lai J.C.K., Cooper A.J.L. Alpha-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution and effects of inhibitors. JNeurochem 1986, 47:1376-1386.
11. Bai G., Rama Rao K.V., Murthy C.R., et al. Ammonia induces the mitochondrial permeability transition in primary cultures of rat astrocytes. JNeurosci Res 2001, 66:981-991.
12. Knecht K., Michalak A., Rose C., Butterworth R.F. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett 1997, 229:201-203.
13. Record C.O., Buxton B., Chase R.A., et al. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976, 6:387-394.
14. McConnell J.R., Antonson D.L., Ong C.S., et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995, 22:69-74.
15. Zwingmann C., Chatauret N., Liebfritz D., Butterworth R.F. Selective increase in brain lactate synthesis in experimental acute liver failure: results of a 1H-13C NMR study. Hepatology 2003, 37:420-428.
16. Butterworth R.F. Pathophysiology of brain dysfunction in hyperammonemic syndromes: the many faces of glutamine. Metab Genet Med 2014, in press.
17. Cooper A.J.L., Gross M. The glutamate transaminase-w-amidase system in rat and human brain. JNeurochem 1977, 28:771-778.
18. Albrecht J., Norenberg M.D. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 2006, 44:788-794.
19. Mans A.M., DeJoseph M.R., Hawkins R.A. Metabolic abnormalities and grade of encephalopathy in acute liver failure. JNeurochem 1994, 63:1829-1838.
20. Deutz N.E.P., DeGraaf A.A., De Haan J.G., et al. Invivo brain 1H-NMR spectroscopy (1H-MRS) during acute hepatic encephalopathy (HE). Advances in Ammonia Metabolism and Hepatic Encephalopathy 1988, 439-446. Excerpta Medica, Amsterdam. P.B. Soeters (Ed.).
21. Chatauret N., Rose C., Therrien G., Butterworth R.F. Mild hypothermia prevents cerebral edema and CSF lactate accumulation in acute liver failure. Metab Brain Dis 2001, 16:95-102.
22. Peeling J., Shoemaker L., Gauthier T., et al. Cerebral metabolic and histological effects of thioacetamide-induced liver failure. Am J Phys 1993, 265:G572-G578.
23. Tofteng F., Jorgensen L., Hansen B.A., et al. Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology 2002, 36:1333-1340.
24. Nyberg S.L., Cerra F.B., Gruetter R. Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg 1998, 4:158-165.
25. Staub F., Baethmann, Peters J., et al. Effects of lactic acidosis on glial cell volume and viability. JCereb Blood Flow Metab 1990, 10:866-876.
26. Eng L.F., GhirnikarR S., Lee Y.L. Glial fibrillary acidic protein: GFAP-31 years (1969-2000). Neurochem Res 2000, 25:1439-1451.
27. Belanger M., Desjardins P., Chatauret N., Butterworth R.F. Loss of expression of glial fibrillary acidic protein in acute hyperammonemia. Neurochem Int 2002, 41:155-160.
28. Norenberg N.D., Neary J.T., Norenberg L.O., et al. Ammonia-induced decrease in glial fibrillary acidic protein in cultured astrocytes. JNeuropathol Exp Neurol 1990, 49:399-405.
29. Michalak A., Rose C., Butterworth J., Butterworth R.F. Neuroactive amino acids and glutamate(NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology 1996, 24:908-913.
30. Zwingmann C., Desjardins P., Hazell A., Butterworth R.F. Reduced expression of astrocytic glycine transporter GLYT-1 in acute liver failure. Metab Brain Dis 2002, 17:263-273.
31. Chaudhry F.A., Krisaj D., Larsson P., et al. Coupled and uncoupled proton movement by amino acid transport system N. EMBO J 2001, 20:7041-7051.
32. Cubelos B., Gonzales-Gonzales I.M., Gimenez C., et al. Amino acid transporter SNAT-5 localises to glial cells in the rat brain. Glia 2005, 49:230-244.
33. Desjardins P., Du T., Jiang W., et al. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem Int 2012, 60:690-696.
34. Fischbarq J., Kuang K.Y., Vera J.C., et al. Glucose transporters serve as water channels. Proc Natl Acad Sci USA 1990, 87:3244-3247.
35. Belanger M., Desjardins P., Chatauret N., et al. Selectively increased expression of the astrocytiv/endothelial glucose transporter protein GLUT1 in acute liver failure. Glia 2006, 53:557-562.
36. Belanger M., Desjardins P., Chatauret N., et al. Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure. JHepatol 2005, 42:694-699.
37. Itzhak Y., Roig-Cantisano A., Dombro R.S., et al. Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 1995, 705:345-348.
38. Jiang W., Desjardins P., Butterworth R.F. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. JNeurochem 2009, 109:485-493.
39. McMillin M., Galindo C., Frampton G.A., et al. Increased neuronal chemokine (CCL2/MCP1) expression is associated with hepatic encephalopathy and contributes to neurological decline. Hepatology 2012, 56(suppl 1):958A.
40. Thrane V.R., Thrane A.S., Chanag J., et al. Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy. Neuroscience 2012, 220:247-255.
41. Bemeur C., Qu H., Desjardins P., Butterworth R.F. IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure. Neurochem Int 2010, 56:213-216.
42. Butterworth R.F. Hepatic encephalopathy: a central neuroinflammatory disorder?. Hepatology 2011, 53:1372-1376.
43. Jiang W., Desjardins P., Butterworth R.F. Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia. JCereb Blood Flow Metab 2009, 29:944-952.
44. Wright G., Shawcross D., Olde Daminck S.W., Jalan R. Brain cytokine flux in acute liver failure and its relationship with intracranial hypertension. Metab Brain Dis 2007, 22:375-388.
45. Rolando N., Wade J., Davalos M., et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32:734-739.
46. Bernal W., Donaldson P., Underhill J., et al. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. JHepatol 1998, 29:53-59.
47. Bemeur C., Butterworth R.F. Liver-brain proinflammatory signalling in acute liver failure: role in the pathogenesis of hepatic encephalopathy and brain edema. Metab Brain Dis 2013, 28:145-150.
48. D'Mello C., Le T., Swain M.G. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor a signalling during peripheral organ inflammation. JNeurosci 2009, 29:2089-2102.
49. Andersson A.K., Ronnback L., Hansson E. Lactate induces tumor necrosis factor-alpha, interleukin-6 and interleukin-1beta release in microglial and astroglial-enriched primary cultures. JNeurochem 2005, 93:1327-1333.
50. Lee W.M. Acute liver failure in the United States. Semin Liver Dis 2003, 23:217-226.
51. Rose C., Michalak A., Pannunzio, et al. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000, 31:872-877.
52. Acharya S.K., Bhatia V., Sreenivas V., et al. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind randomized, placebo-controlled trial. Gastroenterology 2009, 136:2159-2168.
53. Ytrebo L.M., Kristiansen R.G., Maehre H., et al. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure. Hepatology 2009, 50:165-174.
54. Traber P., DalCanto M., Ganger D., et al. Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization. Gastroenterology 1989, 96:885-891.
55. Jalan R., Olde Daminck S.W., Deutz N.E., et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999, 1:1164-1168.
56. Chatauret N., Zwingmann C., Rose C., et al. Effects of hypothermia on brain glucose metabolism in acute liver failure : a H/C nuclear magnetic resonance study. Gastroenterology 2003, 125:815-824.
57. Vaquero J., Belanger M., James L., et al. Mild hypothermia attenuates liver injury and improves survival in mice with acetaminophen toxicity. Gastroenterology 2007, 132:3722-3733.
58. Vaquero J., Butterworth R.F. Mild hypothermia for the treatment of acute liver failure: what are we waiting for?. Nat Clin Pract Gastroenterol Hepatol 2007, 10:528-529.
59. Harrison P.M., Keays R., Bray G.P., et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990, 335:1572-1573.
60. Bemeur C., Vaquero J., Desjardins P., Butterworth R.F. N-acetyl cysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms. Metab Brain Dis 2010, 25:241-249.
61. James L.P., McCullough S.S., Lamps L.W., et al. Effect of N-acetyl cysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol Sci 2003, 75:458-467.
62. Chastre A., Belanger M., Beauchesne E., et al. Inflammatory cascades driven by tumor necrosis factor alpha play a major role in the progression of acute liver failure and its neurological complications. PLos One 2012, 7:e49670.
63. Vogels B.A., Maas M.A., Daalhuisen J., et al. Memantine, a non-competitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute liver failure encephalopathy in rats. Hepatology 1997, 25:820-827.
64. Basile A.S., Hughes R.D., Harrison P.M., et al. Elevated brain concentrations of 1,4 benzodiazepines in fulminant hepatic failure. NEngl J Med 1991, 325:473-478.
65. Van der Rigt C.C., de Knegt R.J., Schalm S.W., et al. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit. Metab Brain Dis 1990, 5:131-141.
66. Widler P., Fisch H.U., Schoch P., et al. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat. Hepatology 1993, 18:1459-1464.
67. Ahboucha S., Coyne L., Hirakawa R., et al. An interaction betweenbenzodiazepines and neuroactive steroids at GABA-A receptors in cultured hippocampal neurons. Neurochem Int 2006, 48:703-707.